Cannabinoid Receptor Interacting Protein 1a (CRIP1a): Function and Structure

Cannabinoid receptor interacting protein 1a (CRIP1a) is an important CB1 cannabinoid receptor-associated protein, first identified from a yeast two-hybrid screen to modulate CB1-mediated N-type Ca2+ currents. In this paper we review studies of CRIP1a function and structure based upon in vitro experiments and computational chemistry, which elucidate the specific mechanisms for the interaction of CRIP1a with CB1 receptors. N18TG2 neuronal cells overexpressing or silencing CRIP1a highlighted the ability of CRIP1 to regulate cyclic adenosine 3′,5′monophosphate (cAMP) production and extracellular signal-regulated kinase (ERK1/2) phosphorylation. These studies indicated that CRIP1a attenuates the G protein signaling cascade through modulating which Gi/o subtypes interact with the CB1 receptor. CRIP1a also attenuates CB1 receptor internalization via β-arrestin, suggesting that CRIP1a competes for β-arrestin binding to the CB1 receptor. Predictions of CRIP1a secondary structure suggest that residues 34-110 are minimally necessary for association with key amino acids within the distal C-terminus of the CB1 receptor, as well as the mGlu8a metabotropic glutamate receptor. These interactions are disrupted through phosphorylation of serines and threonines in these regions. Through investigations of the function and structure of CRIP1a, new pharmacotherapies based upon the CRIP-CB1 receptor interaction can be designed to treat diseases such as epilepsy, motor dysfunctions and schizophrenia.

[1]  P. Morales,et al.  Structural Insights into CB1 Receptor Biased Signaling , 2019, International journal of molecular sciences.

[2]  D. Lodge,et al.  Ventral hippocampal overexpression of Cannabinoid Receptor Interacting Protein 1 (CNRIP1) produces a schizophrenia-like phenotype in the rat , 2019, Schizophrenia Research.

[3]  Ron O. Dror,et al.  Structure of a Signaling Cannabinoid Receptor 1-G Protein Complex , 2019, Cell.

[4]  Anjali D. Ganjiwale,et al.  In silico interaction analysis of cannabinoid receptor interacting protein 1b (CRIP1b) - CB1 cannabinoid receptor. , 2017, Journal of molecular graphics & modelling.

[5]  Shan Jiang,et al.  Crystal structures of agonist-bound human cannabinoid receptor CB1 , 2017, Nature.

[6]  V. Di Marzo,et al.  Allodynia Lowering Induced by Cannabinoids and Endocannabinoids (ALICE) , 2017, Pharmacological research.

[7]  Mostafa H. Ahmed,et al.  CRIP1a inhibits endocytosis of G‐protein coupled receptors activated by endocannabinoids and glutamate by a common molecular mechanism , 2017, Journal of neurochemistry.

[8]  C. Bass,et al.  Cannabinoid Receptor Interacting Protein 1a Competition with β-Arrestin for CB1 Receptor Binding Sites , 2017, Molecular Pharmacology.

[9]  Jie Yin,et al.  High-resolution crystal structure of the human CB1 cannabinoid receptor , 2016, Nature.

[10]  C. Bass,et al.  Cannabinoid receptor interacting protein suppresses agonist‐driven CB1 receptor internalization and regulates receptor replenishment in an agonist‐biased manner , 2016, Journal of neurochemistry.

[11]  R. Stevens,et al.  Crystal Structure of the Human Cannabinoid Receptor CB1 , 2016, Cell.

[12]  V. Di Marzo,et al.  From Phytocannabinoids to Cannabinoid Receptors and Endocannabinoids: Pleiotropic Physiological and Pathological Roles Through Complex Pharmacology. , 2016, Physiological reviews.

[13]  S. Leone‐Kabler,et al.  CB1 cannabinoid receptor-mediated increases in cyclic AMP accumulation are correlated with reduced Gi/o function , 2016, Journal of basic and clinical physiology and pharmacology.

[14]  H. Luhmann,et al.  Cannabinoid receptor-interacting protein Crip1a modulates CB1 receptor signaling in mouse hippocampus , 2015, Brain Structure and Function.

[15]  R. Gizatullin,et al.  The CCDC55 couples cannabinoid receptor CNR1 to a putative DISC1 schizophrenia pathway , 2015, Neuroscience.

[16]  Jordan O. Cox,et al.  Cannabinoid Receptor–Interacting Protein 1a Modulates CB1 Receptor Signaling and Regulation , 2015, Molecular Pharmacology.

[17]  C. Bass,et al.  Cannabinoid receptor interacting protein (CRIP1a) attenuates CB1R signaling in neuronal cells. , 2015, Cellular signalling.

[18]  K. Mackie,et al.  Mutation of Putative GRK Phosphorylation Sites in the Cannabinoid Receptor 1 (CB1R) Confers Resistance to Cannabinoid Tolerance and Hypersensitivity to Cannabinoids in Mice , 2014, The Journal of Neuroscience.

[19]  Mostafa H. Ahmed,et al.  Predicting the molecular interactions of CRIP1a-cannabinoid 1 receptor with integrated molecular modeling approaches. , 2014, Bioorganic & medicinal chemistry letters.

[20]  L. Hunyady,et al.  Differential beta-arrestin2 requirements for constitutive and agonist-induced internalization of the CB cannabinoid receptor. , 2013 .

[21]  L. Hunyady,et al.  Differential β-arrestin2 requirements for constitutive and agonist-induced internalization of the CB1 cannabinoid receptor , 2013, Molecular and Cellular Endocrinology.

[22]  C. Bass,et al.  Striatal CB1 and D2 receptors regulate expression of each other, CRIP1A and delta opioid systems , 2013, Journal of neurochemistry.

[23]  Peter T. Nguyen,et al.  β-Arrestin2 Regulates Cannabinoid CB1 Receptor Signaling and Adaptation in a Central Nervous System Region–Dependent Manner , 2012, Biological Psychiatry.

[24]  D. Centonze,et al.  Effects of palmitoylation of Cys415 in helix 8 of the CB1 cannabinoid receptor on membrane localization and signalling , 2012, British journal of pharmacology.

[25]  George D. Dalton,et al.  Cannabinoid CB1 receptors transactivate multiple receptor tyrosine kinases and regulate serine/threonine kinases to activate ERK in neuronal cells , 2012, British journal of pharmacology.

[26]  L. Kanit,et al.  Changes in the cannabinoid (CB1) receptor expression level and G-protein activation in kainic acid induced seizures , 2012, Epilepsy Research.

[27]  Ryan T. Strachan,et al.  Distinct Phosphorylation Sites on the β2-Adrenergic Receptor Establish a Barcode That Encodes Differential Functions of β-Arrestin , 2011, Science Signaling.

[28]  A. Makriyannis,et al.  Binding between a distal C-terminus fragment of cannabinoid receptor 1 and arrestin-2. , 2011, Biochemistry.

[29]  D. Selley,et al.  Cannabinoid CB1 receptor‐interacting proteins: novel targets for central nervous system drug discovery? , 2010, British journal of pharmacology.

[30]  A. Howlett,et al.  CB(1) cannabinoid receptors and their associated proteins. , 2010, Current medicinal chemistry.

[31]  Achani K. Yatawara,et al.  Structural analysis of the human cannabinoid receptor one carboxyl‐terminus identifies two amphipathic helices , 2009, Biopolymers.

[32]  C. Breivogel,et al.  Sensitivity to Δ9-tetrahydrocannabinol is selectively enhanced in beta-arrestin2−/− mice , 2008, Behavioural pharmacology.

[33]  T. Daigle,et al.  Regulation of CB1 cannabinoid receptor internalization by a promiscuous phosphorylation‐dependent mechanism , 2008, Journal of neurochemistry.

[34]  Masahiko Watanabe,et al.  Downregulation of the CB1 Cannabinoid Receptor and Related Molecular Elements of the Endocannabinoid System in Epileptic Human Hippocampus , 2008, The Journal of Neuroscience.

[35]  T. Daigle,et al.  Rapid CB1 cannabinoid receptor desensitization defines the time course of ERK1/2 MAP kinase signaling , 2008, Neuropharmacology.

[36]  M. Elphick,et al.  CB1 Cannabinoid Receptor Activity Is Modulated by the Cannabinoid Receptor Interacting Protein CRIP 1a , 2007, Molecular Pharmacology.

[37]  R. Mercier,et al.  Interaction of a fragment of the cannabinoid CB1 receptor C‐terminus with arrestin‐2 , 2007, FEBS letters.

[38]  Beat Lutz,et al.  The Endocannabinoid System Controls Key Epileptogenic Circuits in the Hippocampus , 2006, Neuron.

[39]  T. Rubino,et al.  Changes in the expression of G protein-coupled receptor kinases and β-arrestins in mouse brain during cannabinoid tolerance , 2006, Molecular Neurobiology.

[40]  A. Howlett,et al.  Chemically Distinct Ligands Promote Differential CB1 Cannabinoid Receptor-Gi Protein Interactions , 2005, Molecular Pharmacology.

[41]  J. Shim,et al.  CB(1) cannabinoid receptor-G protein association: a possible mechanism for differential signaling. , 2002, Chemistry and physics of lipids.

[42]  M. Herkenham,et al.  International Union of Pharmacology. XXVII. Classification of Cannabinoid Receptors , 2002, Pharmacological Reviews.

[43]  M. Kouznetsova,et al.  Desensitization of cannabinoid-mediated presynaptic inhibition of neurotransmission between rat hippocampal neurons in culture. , 2002, Molecular pharmacology.

[44]  J. Nie,et al.  Structural Domains of the CB1 Cannabinoid Receptor That Contribute to Constitutive Activity and G-Protein Sequestration , 2001, The Journal of Neuroscience.

[45]  J. Nie,et al.  The proximal and distal C-terminal tail domains of the CB1 cannabinoid receptor mediate G protein coupling , 2001, Neuroscience.

[46]  A. Howlett,et al.  CB1 receptor–G protein association , 2001 .

[47]  K. Mackie,et al.  Internalization and Recycling of the CB1 Cannabinoid Receptor , 1999, Journal of neurochemistry.

[48]  K. Mackie,et al.  Distinct Domains of the CB1 Cannabinoid Receptor Mediate Desensitization and Internalization , 1999, The Journal of Neuroscience.

[49]  S. M. Cowsik,et al.  Regulation of Gi by the CB1 cannabinoid receptor C-terminal juxtamembrane region: structural requirements determined by peptide analysis. , 1999, Biochemistry.

[50]  A. Howlett,et al.  Differential receptor-G-protein coupling evoked by dissimilar cannabinoid receptor agonists. , 1998, Cellular signalling.

[51]  E. Dainese,et al.  Role of palmitoylation of cysteine 415 in functional coupling CB1 receptor to Gαi2 protein , 2018, Biotechnology and applied biochemistry.

[52]  H. Bradshaw,et al.  Endocannabinoid Analytical Methodologies: Techniques That Drive Discoveries That Drive Techniques. , 2017, Advances in pharmacology.

[53]  A. Howlett,et al.  CB1 and CB2 Receptor Pharmacology. , 2017, Advances in pharmacology.

[54]  M. Elphick,et al.  CB 1 Cannabinoid Receptor Activity Is Modulated by the Cannabinoid Receptor Interacting Protein CRIP 1 a , 2007 .

[55]  T. Rubino,et al.  Changes in the expression of G protein-coupled receptor kinases and beta-arrestins in mouse brain during cannabinoid tolerance: a role for RAS-ERK cascade. , 2006, Molecular neurobiology.

[56]  A. Howlett,et al.  CB1 receptor-G protein association. Subtype selectivity is determined by distinct intracellular domains. , 2001, European journal of biochemistry.

[57]  A. Howlett,et al.  The CB(1) cannabinoid receptor juxtamembrane C-terminal peptide confers activation to specific G proteins in brain. , 2000, Molecular pharmacology.

[58]  A. Howlett,et al.  Solubilization of the cannabinoid receptor from rat brain and its functional interaction with guanine nucleotide-binding proteins. , 1993, Molecular pharmacology.